DENESE GAUGHAN: Open Payments
NPI 1841286671 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,549 in 110 payments from 11 companies in 2025. Trend: 2023 $1,691 · 2024 $1,297 · 2025 $1,549
Food & beverage: $1,549
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 79 | $977 |
| GENZYME CORPORATION | 9 | $157 |
| Aimmune Therapeutics, Inc. | 6 | $110 |
| Janssen Biotech, Inc. | 4 | $95 |
| Ipsen Biopharmaceuticals, Inc | 2 | $51 |
| Phathom Pharmaceuticals, Inc. | 4 | $38 |
| PFIZER INC. | 2 | $38 |
| Madrigal Pharmaceuticals | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: RINVOQ, CREON, DUPIXENT, TREMFYA, VOWST, IQIRVO, ZENPEP, SKYRIZI.
Industry payments across MD — which companies pay providers there.
